InfuSystem (NYSE:INFU) Now Covered by Lake Street Capital

Lake Street Capital assumed coverage on shares of InfuSystem (NYSE:INFU) in a research note published on Monday, MarketBeat.com reports. The brokerage issued a buy rating and a $15.00 price objective on the stock.

Separately, Roth Capital initiated coverage on InfuSystem in a research note on Tuesday, July 22nd. They set a “buy” rating and a $12.00 price objective on the stock. Three equities research analysts have rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company. According to MarketBeat, the stock has an average rating of “Strong Buy” and a consensus price target of $13.33.

InfuSystem Stock Performance

Shares of InfuSystem stock opened at $10.41 on Monday. The company has a market capitalization of $212.63 million, a PE ratio of 173.53 and a beta of 1.82. InfuSystem has a 12 month low of $4.61 and a 12 month high of $11.04. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. The stock’s fifty day simple moving average is $8.51 and its 200 day simple moving average is $6.62.

Insider Activity

In other InfuSystem news, Director Scott Shuda sold 5,752 shares of InfuSystem stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $9.67, for a total value of $55,621.84. Following the sale, the director owned 94,000 shares of the company’s stock, valued at $908,980. This trade represents a 5.77% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 11.40% of the stock is owned by corporate insiders.

Institutional Trading of InfuSystem

Several hedge funds and other institutional investors have recently modified their holdings of INFU. CWM LLC raised its stake in shares of InfuSystem by 1,160.1% in the 2nd quarter. CWM LLC now owns 4,826 shares of the company’s stock valued at $30,000 after purchasing an additional 4,443 shares during the period. Raymond James Financial Inc. bought a new position in shares of InfuSystem in the 2nd quarter valued at about $33,000. BNP Paribas Financial Markets grew its holdings in shares of InfuSystem by 67.9% in the 4th quarter. BNP Paribas Financial Markets now owns 6,844 shares of the company’s stock valued at $58,000 after acquiring an additional 2,768 shares in the last quarter. Jump Financial LLC bought a new position in shares of InfuSystem in the 1st quarter valued at about $58,000. Finally, Williams & Novak LLC bought a new position in shares of InfuSystem in the 2nd quarter valued at about $77,000. Institutional investors and hedge funds own 71.13% of the company’s stock.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.